Corrigendum to "De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel": [Annals of Oncology 28 (2017) 2768-2772].

Autor: Nitz UA; West German Study Group GmbH, Moenchengladabach, Germany; Evangelical Hospital Johanniter Bethesda, Breast Center Niederrhein, Moenchengladbach, Germany., Gluz O; West German Study Group GmbH, Moenchengladabach, Germany; Evangelical Hospital Johanniter Bethesda, Breast Center Niederrhein, Moenchengladbach, Germany; University of Cologne, Cologne, Germany. Electronic address: oleg.gluz@wsg-online.com., Christgen M; Institute of Pathology, Medical School Hannover, Hannover, Germany., Grischke EM; Department of Gynecology and Obstetrics, University Clinics Tuebingen, Tuebingen, Germany., Augustin D; Breast Center Ostbayern, Deggendorf, Germany., Kuemmel S; Breast Center, Clinics Essen-Mitte, Essen, Germany., Braun M; Rotkreuz Clinics Munich Breast Center, Munich, Germany., Potenberg J; Department of Oncology Evangelical Waldkrankenhaus Berlin, Berlin, Germany., Kohls A; Department of Gynecology and Obstetrics, Evangelical Hospital, Ludwigsfelde, Germany., Krauss K; Department of Gynecology and Obstetrics, University Clinics RWTH, Aachen, Germany., Stefek A; Breast Center, Evangelical Hospital Johanniter, Stendal, Germany., Schumacher C; Breast Center, St. Elisabeth Hospital Cologne, Cologne, Germany., Forstbauer H; Oncology Practice Network, Troisdorf, Germany., Reimer T; Department of Gynecology and Obstetrics, University Clinics Rostock, Suedstadt, Germany., Fischer H; Breast Center, Evangelical Hospital Gelsenkirchen, Gelsenkirchen, Germany., Liedtke C; Department of Gynecology and Obstetrics, University Clinics Schleswig-Holstein/Campus Luebeck, Luebeck, Germany; Charite Berlin, Germany., Wuerstlein R; Breast Center, Department of Gynecology and Obstetrics, University of Munich (LMU) and CCCLMU, Munich, Germany., Schumacher J; Palleos Healthcare, Statistics, Wiesbaden, Germany., Kates R; West German Study Group GmbH, Moenchengladabach, Germany., Kreipe H; University of Cologne, Cologne, Germany., Harbeck N; West German Study Group GmbH, Moenchengladabach, Germany; Breast Center, Department of Gynecology and Obstetrics, University of Munich (LMU) and CCCLMU, Munich, Germany.
Jazyk: angličtina
Zdroj: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2022 Mar; Vol. 33 (3), pp. 355. Date of Electronic Publication: 2022 Jan 07.
DOI: 10.1016/j.annonc.2021.12.008
Databáze: MEDLINE